Results 261 to 270 of about 36,124 (280)

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Nature, 2017
Christopher Abbosh, Nicolai J Birkbak, Mariam Jamal-Hanjani   +2 more
exaly  

Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease

Nature Reviews Clinical Oncology, 2016
Rafael Rosell, Niki Karachaliou
exaly  

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

Annals of Oncology, 2023
exaly  

Molecular diagnostics, including CTC and ctDNA

Clinical Chemistry and Laboratory Medicine (CCLM)
openaire   +2 more sources

Tracking ctDNA to evaluate relapse risk

Nature Reviews Clinical Oncology, 2015
Diana Romero
exaly  

When ctDNA says ‘maybe’: improving the dynamics of MRD trials

Nature Reviews Clinical Oncology
Julien Taieb
exaly  

Serial ctDNA to understand PARPi resistance

Nature Reviews Urology
openaire   +2 more sources

Predicting outcomes in CNS lymphoma with ctDNA

Blood
Jane N. Winter, Andres J. M. Ferreri
openaire   +2 more sources

Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma

Nature Medicine
James R M Black, Takahiro Karasaki, Maise Al Bakir   +2 more
exaly  

ctDNA-Status als neuer Prognosemarker?

Im Fokus Onkologie
openaire   +1 more source